Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors 13F holdings
Ole Andreas Halvorsen's Portfolio
- Portfolio value:
- $24.43B≈
- # of securities:
- 86
- Reported for:
- 30 Jun 2023 (Q2)
- Latest filing date:
- 14 Aug 2023
What stocks did Ole Andreas Halvorsen own in 2023 Q2?
What was Ole Andreas Halvorsen's 2023 Q2 portfolio?
Viking Global Investors has disclosed a total of 86 security holdings in their (2023 Q2) SEC 13F filing(s) with portfolio value of $24,426,457,264.
Viking Global Investors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ole Andreas Halvorsen's original 13F reports (2023 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
85 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Visa Inc, CL-A
|
6.94%
|
7,140,286
|
$237.48
|
+48.82%($353.42)
|
$1,695,675,119
|
2016 Q3
|
≈ 7.00 years
|
Common Stock
|
+8.84% (+580.22K)
|
+0.56%
|
|
|
|
Danaher Corp
|
4.18%
|
4,256,761
|
$240.00
|
-19.97%($192.06)
|
$1,021,622,640
|
2023 Q2
|
≈ 0.25 years
|
Common Stock
|
new
|
+4.18%
|
|
|
|
Api GroupCorp
|
3.82%
|
34,199,532
|
$27.26
|
+45.14%($39.56)
|
$932,279,242
|
2020 Q2
|
≈ 3.25 years
|
Common Stock
|
+0.32% (+109.25K)
|
+0.01%
|
|
|
|
Philip Morris International Inc
|
3.62%
|
9,055,492
|
$97.62
|
+98.85%($194.12)
|
$883,997,129
|
2023 Q2
|
≈ 0.25 years
|
Common Stock
|
new
|
+3.62%
|
|
|
|
UnitedHealth Group Incorporated
|
3.53%
|
1,794,275
|
$480.64
|
-12.57%($420.23)
|
$862,400,336
|
2022 Q3
|
≈ 1.00 year
|
Common Stock
|
-14.56% (-305.72K)
|
-0.69%
|
|
|
|
GE Aerospace
|
3.21%
|
7,138,176
|
$109.85
|
+221.98%($353.70)
|
$784,128,634
|
2020 Q4
|
≈ 2.75 years
|
Common Stock
|
-17.12% (-1.47M)
|
-0.76%
|
|
|
|
ROIVANT SCIENCES LTD
|
3.10%
|
75,238,700
|
$10.08
|
+249.40%($35.22)
|
$758,406,096
|
2021 Q4
|
≈ 1.75 years
|
Common Stock
|
-14.73% (-13M)
|
-0.61%
|
|
|
|
Meta Platforms Inc
|
3.05%
|
2,594,548
|
$286.98
|
+109.74%($601.91)
|
$744,583,385
|
2020 Q4
|
≈ 2.75 years
|
Common Stock
|
-19.67% (-635.37K)
|
-0.86%
|
|
|
|
Fortive Corp
|
3.00%
|
9,798,229
|
$74.77
|
-17.19%($61.92)
|
$732,613,582
|
2019 Q3
|
≈ 4.00 years
|
Common Stock
|
+54.39% (+3.45M)
|
+1.06%
|
|
|
|
Workday Inc
|
2.81%
|
3,038,619
|
$225.89
|
-40.69%($133.96)
|
$686,393,646
|
2023 Q1
|
≈ 0.50 years
|
Common Stock
|
+372.98% (+2.4M)
|
+2.22%
|
|
Completely sold out
15 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Block, Inc
|
-2,354,123
|
-0.76%
|
2021 Q4
|
≈ 1.50 years
|
|
|
|
Molina Healthcare Inc
|
-594,553
|
-0.75%
|
2019 Q3
|
≈ 3.75 years
|
|
|
|
Axa Equitable Holdings Inc
|
-3,989,446
|
-0.48%
|
2022 Q4
|
≈ 0.50 years
|
|
|
|
Inspire Medical Systems Inc
|
-346,576
|
-0.38%
|
2022 Q1
|
≈ 1.25 years
|
|
|
|
Charles River Laboratories
|
-394,089
|
-0.37%
|
2021 Q1
|
≈ 2.25 years
|
|
|
|
Catalent Inc
|
-1,201,210
|
-0.37%
|
2018 Q1
|
≈ 5.25 years
|
|
|
|
The Travelers Companies Inc
|
-378,345
|
-0.3%
|
2023 Q1
|
≈ 0.25 years
|
|
|
|
Snowflake Inc
|
-382,757
|
-0.28%
|
2023 Q1
|
≈ 0.25 years
|
|
|
|
Intellia Therapeutics Inc
|
-1,569,545
|
-0.27%
|
2021 Q2
|
≈ 2.00 years
|
|
|
|
Boston Scientific Corp
|
-1,136,881
|
-0.27%
|
2018 Q3
|
≈ 4.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.